UPPER Rapid Quantitative Determination for whole range C-Reactive Protein (hs-CRP+CRP) by DIGFA Method - Indonesia BPOM Medical Device Registration

UPPER Rapid Quantitative Determination for whole range C-Reactive Protein (hs-CRP+CRP) by DIGFA Method is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20305320806. The device is manufactured by SHANGHAI UPPER BIOTECH PHARMA CO., LTD. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. GOLDEN MEDIKA MANDIRI.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.